Hovione to support production of antiviral Veklury for COVID-19
Hovione has signed a partnership agreement with Ligand to significantly ramp up the production output of Captisol
Breaking News
Elementar warns of counterfeit drug crisis
The threat posed to the pharmaceutical industry by substandard and falsified medicines is on the rise, according to ...
Abcam offers bioactive proteins for drug discovery
Sourcing high-quality proteins with batch-to-batch consistency can be a challenge, as endotoxin levels and/or non- ...
DuPont to virtually showcase offering at Festival of Pharma
DuPont’s technical leaders will speak on topical trends to enhancing global focus on customer needs during the ...
Scaling-up the pharmaceutical supply chain with digitisation: part II
To optimise their efficiency and profitability, next-generation supply chains must be built on a foundation of optimal ...
Boosting the taste, stability and shelf-life of probiotic supplements
To support the stability, formulation and viability of micro-organisms for a healthy gut, BENEO presents galenIQ 721 at ...
Roquette names Barentz a strategic partner for US distribution
Distributor will carry the entire Roquette pharmaceutical portfolio for customers in the United States
API sourcing: what to look for in a supplier
Jonathan Knight, Director of Market Intelligence and New Technologies at Cambrex, presents an overview of the API ...
Isotope producer expands benzene and bromobenzene capacities
Cambridge Isotope Laboratories has recently announced a capacity expansion for deuterated benzene
Seqens inaugurates new HPAPI unit at French site
The new unit is a result of a $35 million investment in one of the three leading technologies in pharmaceutical ...
Identifying nitrosamines in pharmaceutical products
The TEA detector has long been an industry standard for nitrosamine analysis in food and beverages, which can also be ...
Developing innovative antivirals for novel viruses
Since the emergence of COVID-19, researchers worldwide have striven to study and overcome this new disease and the ...
Nitrosamines: Information for Marketing Authorisation Holders
Nitrosamine impurities have been in the regulatory spotlight since they were discovered in several blood pressure ...
AbCellera acquires OrthoMab bispecific platform
AbCellera has acquired the OrthoMab bispecific platform from Dualogics
Japanese CDMO to invest $100m in capacity and portfolio
Bushu Pharmaceutical's new facility is an important component in the company's "Asia hub" strategy
In Brief
Most Popular in Ingredients
Featured Companies
Reports
